Prevalence of errors in lab-made plasmids across the globe.

Area of Science:

• Molecular Biology
• Biotechnology
• Gene Therapy

Background:

• Plasmids are essential tools in life sciences research and therapeutics.
• Currently, most laboratories custom-build their plasmids without systematic quality data.
• The quality of lab-constructed plasmids is largely uncharacterized.

Purpose of the Study:

• To systematically assess the quality of lab-made plasmids used globally.
• To identify common errors in plasmid design and sequence.
• To propose standards for improving plasmid quality in research and medicine.

Main Methods:

• Conducted a broad survey of plasmids from academic and industrial laboratories worldwide.
• Analyzed plasmid sequences for design and sequence errors.
• Investigated mutations in transfer plasmids for adeno-associated virus (AAV) vectors, focusing on inverted terminal repeat (ITR) regions.
• Identified genes that are difficult to clone or package due to toxicity.

Main Results:

• Nearly 50% of surveyed plasmids contained design and/or sequence errors.
• Approximately 40% of transfer plasmids for AAV vectors had mutations in ITR regions, linked to GC content.
• A list of genes problematic for cloning or viral packaging due to toxicity was compiled.
• The findings indicate significant quality issues with commonly used lab-made plasmids.

Conclusions:

• Lab-made plasmids frequently contain errors, raising concerns about research reproducibility and therapeutic development.
• Instability in AAV transfer plasmids, particularly ITR mutations, is a significant issue.
• There is a critical need for community-wide standards, such as good vector practice (GVP), to ensure plasmid quality.